Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data.

Waguespack SG, Brose MS, Lin JJ, McDermott R, Almubarak M, Bauman J, Casanova M, Kummar S, Lee SH, Rieke DT, Oh DY, Qi C, Neu N, Burcoveanu DI, Mussi CE, Drilon A, Hong DS, Cabanillas ME

Open source

DOI: 10.1530/erc-25-0531
Published: 2026 Aug 1
Container: Endocrine-related cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1530/erc-25-0531,
  title = {Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data.},
  author = {Waguespack SG and Brose MS and Lin JJ and McDermott R and Almubarak M and Bauman J and Casanova M and Kummar S and Lee SH and Rieke DT and Oh DY and Qi C and Neu N and Burcoveanu DI and Mussi CE and Drilon A and Hong DS and Cabanillas ME},
  year = {2026},
  journal = {Endocrine-related cancer},
  doi = {10.1530/erc-25-0531},
  url = {https://doi.org/10.1530/erc-25-0531}
}

RIS

TY  - JOUR
TI  - Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data.
AU  - Waguespack SG
AU  - Brose MS
AU  - Lin JJ
AU  - McDermott R
AU  - Almubarak M
AU  - Bauman J
AU  - Casanova M
AU  - Kummar S
AU  - Lee SH
AU  - Rieke DT
AU  - Oh DY
AU  - Qi C
AU  - Neu N
AU  - Burcoveanu DI
AU  - Mussi CE
AU  - Drilon A
AU  - Hong DS
AU  - Cabanillas ME
PY  - 2026
JO  - Endocrine-related cancer
DO  - 10.1530/erc-25-0531
UR  - https://doi.org/10.1530/erc-25-0531
ER  -

APA

SG, W., MS, B., JJ, L., R, M., M, A., J, B., M, C., S, K., SH, L., DT, R., DY, O., C, Q., N, N., DI, B., CE, M., A, D., DS, H., & ME, C. (2026). Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data.. Endocrine-related cancer. https://doi.org/10.1530/erc-25-0531

Source records

pubmed · retrieved 2026-09-24T21:51:36.675Z